NPI Research
-
NPI – Assessment of E-commerce portal for Medical Devices in Latin America
- May 24, 2020
- Posted by: Team EMeRG
- Category: GTM Strategy, ICU equipment, Latin America, NPI Research, Operating Room devices, Patient Monitoring
No Comments
Our Client: A global medical technologies firm with specialization in ICU and OR medical devices Challenge Statement: Our client was looking to introduce a new e-commerce platform for medical devices as well as spare parts across geographies such as Colombia, Mexico etc. The client wanted to understand how the portal should be designed, its key differentiators, types -
Pricing and Value Proposition Assessment for Ultrasound Machines In India
- November 15, 2017
- Posted by: Team EMeRG
- Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, Diagnostic Imaging, Market Entry Assessment, Maternal & Infant Care, NPI Research, Pricing Research, Value Prop Assessment
“45% of the non-owners of ultrasound interviewed were Obs/Gyn specialists, practicing for >16 years. Clearly, adoption of ultrasound in India would take more than just lowering price points…” Overview: Ultrasound Market in India Valued at $170Mn in 2016, the market for diagnostic ultrasound in India is characterized by immense fragmentation. While on the one hand, -
Evaluation of business models and marketing strategies for a Tele-Health solution
- February 13, 2017
- Posted by: Team EMeRG
- Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, Competitive Intelligence, GTM Strategy, Healthcare IT, Market Entry Assessment, NPI Research, Pricing Research, Value Prop Assessment
Overview: Market for Tele-Health solutions in India Limited healthcare access across rural and semi-urban India is causing significant loss w.r.t. disability adjusting life years amounting to economic loses worth $200 trillion. Despite 70% of the population being spread across rural India, urban parts account for 60% of the workforce. Tele-health initiatives, though not highly commercially viable -
Technology assessment for a mobile imaging device with new OS in US and Europe
- December 13, 2016
- Posted by: Team EMeRG
- Category: BY MEDICAL TECHNOLOGIES, Diagnostic Imaging, Europe, Healthcare IT, Market Entry Assessment, Maternal & Infant Care, NPI Research, US
Overview: Operating systems for medical devices Several medical devices OEMs prefer CE or Linux for their products. Key advantages offered by such operating systems: Seamless user-interfaces Ease of use and familiarity for software engineers Linux may be free and open source; while CE offers a fully-integrated development platform However, with medical device utilization shifting to -
New Product Introduction: Non-invasive solution for measuring HbA1c
- October 10, 2016
- Posted by: Team EMeRG
- Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, Competitive Intelligence, Diabetes Management, Ethnographic Research, Market Entry Assessment, NPI Research, Pricing Research, SUBCONTINENT
Overview: Market for HbA1c Tests The global market for Self monitoring blood glucose (SMBG) devices was valued at $11Bn in 2015 and is characterized by intense competition and low entry barriers for low-cost manufacturers. In India, the market for SMBG devices and strips was valued at about $98Mn in 2015.While the annual median expenditure on -
Mapping of Oncology Infrastructure and Need-gap analysis across ASEAN and APAC
- October 5, 2016
- Posted by: Team EMeRG
- Category: AFRICA, ASEAN, BY MEDICAL TECHNOLOGIES, Diagnostic Imaging, GTM Strategy, Market Entry Assessment, NPI Research, Nuclear Medicine Equipment
Overview: Cancer in Emerging markets With 14.9Mn new cancer cases and 8.2Mn cancer deaths in 2013, global incidence of cancer is on the rise. ASEAN itself accounted for about 700,000 new cancer cases in 2015 while 54 African countries contributed to 847,000 new cancer cases. It is further estimated that Less developed countries accounted for -
New Product Introduction: Low-cost visualization device for body orifices
- September 10, 2016
- Posted by: Team EMeRG
- Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, Competitive Intelligence, Ethnographic Research, Market Entry Assessment, NPI Research, Operating Room devices, Pricing Research
Overview: Market for Endoscopic Products in India The global market for endoscopic products was valued at over $29Bn in 2015, growing at over 6% annually. India represents about 0.35% of the global markets, being valued at $115Mn. Rigid endoscopes continue to dominate sales in India, accounting for over 62% of the market revenues. Future innovations -
New Product Introduction and Market Feasibility Assessment: Tele-Monitoring Solution for Critical Care
- January 9, 2016
- Posted by: Team EMeRG
- Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, GTM Strategy, Healthcare IT, ICU equipment, Market Entry Assessment, NPI Research, Patient Monitoring, Value Prop Assessment
Overview: Global Tele-ICU Market Valued at over $1.5Bn, the global market for tele-ICU is growing at double digits. With acute shortage of intensivists across most countries globally, the need for a command center that continuously monitors patients in critical care units is on the rise. The need-gaps are potentially more searing in emerging markets where a -
Feasibility assessment and pricing strategy for the launch of diagnostic lab chains in India
- December 13, 2015
- Posted by: Team EMeRG
- Category: APAC / ASEAN, BY MEDICAL TECHNOLOGIES, Diagnostic Imaging, GTM Strategy, Market Entry Assessment, NPI Research, Pricing Research, Value Prop Assessment
Overview: Market for Diagnostic labs in India In India, 70% of the treatment decisions are made based on lab results. Valued at over $7Bn, the diagnostics industry in India is largely unregulated and unorganized. While accreditation is optional, there are <800 medical labs that have been accredited by NABL. This represents roughly 1% of all -
Business Case Creation for a US-Based Novel Blood Glucose Monitoring Company
- November 18, 2015
- Posted by: Team EMeRG
- Category: APAC / ASEAN, BY BUSINESS CHALLENGES, BY MEDICAL TECHNOLOGIES, Diabetes Management, Market Entry Assessment, NPI Research, Pricing Research
“CGM with infusion pump is very expensive for patients to buy. In India, hardly a few patients have CGM - let alone infusion pumps. Now with newer technology I hope cost comes down and more patients have access to continuous monitoring. In Metropolitan cities around 5 % of the diabetic population would buy SMBG monitors.
- 1
- 2
